checkAd
    Startseite > Aktien > Spruce Biosciences > Nachrichten
    Spruce Biosciences Aktie
    0,7410
     
    USD
    +2,49 %
    +0,0180 USD
    Letzter Kurs 01.06.24 NYSE
    0,7265
     
    USD
    500 STK
    Geldkurs 31.05.24
    0,7461
     
    USD
    100 STK
    Briefkurs 31.05.24
    ISIN: US85209E1091 · WKN: A2QD65 · SYM: SPRB · USA

    Neueste Nachrichten

    Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
    13:00 Uhr · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
    23.05.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
    22.05.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    13.05.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences to Participate in May Investor Conferences
    01.05.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    30.04.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
    22.04.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    21.03.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    14.03.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
    13.03.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
    13.03.24 · Business Wire (engl.) · Spruce Biosciences
    Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    30.01.24 · Business Wire (engl.) · Spruce Biosciences